Nestlé Health Science - Go to Homepage
-
THERAPEUTIC AREAS
-
Educational Resources
-
Resources for Healthcare Professionals
Resources for Your Patients
-
-
OurProducts
-
- OUR PRODUCTS
Obesity
Obesity
By 2030, obesity could affect more than half of the US population.1
Obesity is often an underlying issue behind several of the most common costly, and potentially deadly, health conditions.2 Evidence shows that a decrease in BMI reduces annual medical expenditures and is likely to result in clinically meaningful health benefits.3
At Nestlé Health Science, we are actively engaged in developing nutritional therapies to help reduce obesity and its associated comorbidities, while improving the quality of life of those who are challenged by the condition.
Obesity
Obesity
By 2030, obesity could affect more than half of the US population.1
Obesity is often an underlying issue behind several of the most common costly, and potentially deadly, health conditions.2 Evidence shows that a decrease in BMI reduces annual medical expenditures and is likely to result in clinically meaningful health benefits.3
At Nestlé Health Science, we are actively engaged in developing nutritional therapies to help reduce obesity and its associated comorbidities, while improving the quality of life of those who are challenged by the condition.
